VIDEOS
Celebrating a decade of success.
We’ve reached a milestone worth celebrating, since our Founder and Director, Sarah Griffin first launched MedTechnique Consulting. Thank you to everyone who’s been part of our journey, clients, partners and industry related colleagues. Here’s to many more years of innovation, collaboration and success.
Why you need to conduct a Feasibility Assessment prior to any major medical device reimbursement submission.
Navigating the landscape of reimbursement submissions for new medical devices in the Australian market demands, precision, time, and resources. At MedTechnique Consulting, we recommend a proactive approach: conducting a feasibility assessment prior to any major reimbursement submission. In the third video in our four-part video series, our Director, Sarah Griffin focuses on why it’s crucial to conduct a Feasibility Assessment for your medical device and importantly, the process involved.
Clinical Evidence required for Medical Device reimbursement in Australia
The second video in our four-part video series, Director, Sarah Griffin explores the intricacies of medical device reimbursement and market access in Australia. In this video, Sarah tackles the question most frequently posed by clients: “What clinical evidence is required for a successful medical device reimbursement application?”
Novel Medical Devices in the Australian Market.
Watch our Director and Founder of MedTechnique Consulting, Sarah Griffin latest four-part video series delving into the dynamic landscape of medical device reimbursement and market access in Australia. In this first episode, Sarah shines a spotlight on the intricacies surrounding Novel Medical Devices and gaining reimbursement in the Australian healthcare market.
The Drugs and Devices Australia Webinar 2023.
Hosted by our Director Sarah Griffins and George Papadopoulos, Director of Lucid Health Consulting covering a run-down of all the updates from 2023 in the complex world of drug and device reimbursement applications and strategy in the Australian market. George and Sarah discuss the latest developments in gaining reimbursement in the Australian market, answer attendee questions and share their insights on what to expect in 2024.
The Prostheses List Reforms Update
Webinar by MedTechnique Consulting
If you’re planning an application for the Australian Prostheses List, you’ll need to know about all of the changes that came into effect on 11 September 2023, when a major part of Australian Government’s Prostheses List Reforms were implemented.
Watch our recorded webinar presented by Sarah Griffin, Director of MedTechnique Consulting, and health economist.
Our webinar will walk you through the changes from the Government reform that commenced in 2021, so you are prepared and ready to submit applications for the next Prostheses List round, including:
- A move to a new online platform, the Health Products Portal (HPP)
- New application and listing fees
- New application pathways for different types of devices
- New application form with new information and evidence requirements
The Drugs and Devices Australia Webinar 2022.
Hosted by our Director Sarah Griffin and George Papadopoulos Partner & Director of Lucid Health Consulting, sharing their insights into the complex world of drug and device reimbursement applications and strategy in the Australian market. George and Sarah discuss the latest developments in gaining reimbursement in the Australian market, wrap up the year 2022 and answer webinar attendee’s questions.
The Drugs and Devices Australia Webinar 2021.
Hosted by our Director Sarah Griffin and George Papadopoulos Partner & Director of Lucid Health Consulting, sharing their insights into the complex world of drug and device reimbursement applications and strategy in the Australian market. George and Sarah discuss the latest developments in gaining reimbursement in the Australian market, wrap up the year 2021 and answer webinar attendee’s questions.
Medical Devices Market Entry – Australia, 2021 Webinar.
Hosted by our Director, Sarah Griffin and Kirsty Amland, Director of Meta Medtech Consulting, sharing their insights into the fundamentals of achieving Australian market entry for your medical devices as well as answering any webinar attendee’s questions.
Topics covered included:
- The Australian Healthcare Environment – the challenges and opportunities presented by the geographic, social and economic environments
- Assessing the Market – how to assess the commercial opportunity in Australia for your medical device
- Developing a Winning Strategy – the key considerations for building a successful Australian market entry strategy
- Australian reimbursement and health financing landscape – the risks and opportunities
- Pathways to reimbursement – the different pathways to reimbursement
- Australian Health Technology Assessment – how to prepare
6th Annual Drugs & Devices Australia – Reimbursement Update, 2020.
Hosted by our Director Sarah Griffin and George Papadopoulos Partner & Director of Lucid Health Consulting, sharing their insights into the complex world of drug and device reimbursement applications and strategy in the Australian market. Sarah and George discuss the latest developments in gaining reimbursement in the Australian market.
The 5th Annual Drugs & Devices Australia Webinar – Reimbursement Update
Learn the latest developments in gaining reimbursement in the Australian market and an overview of 2019 by viewing the Fifth Annual Drugs & Devices Australia, Webinar – Reimbursement Australia, 2019.
Please join us for this webinar, hosted by Sarah Griffin, Director of MedTechnique Consulting and George Papadopoulos of Emerald Corporate Group as they discuss the latest developments in gaining reimbursement in the Australian market. George and Sarah share their insights into the complex world of drug and device reimbursement applications and strategy in the Australian market: as well as answering webinar attendee’s questions.
Experts in medical device reimbursement and market access in Australia